RenovoRx Enrolls First Pancreatic Cancer Patient at Columbia University’s New York-Presbyterian Hospital Irving Medical Center in Ongoing TIGeR-PaC Phase III Clinical Trial

RenovoRx, Inc. announced enrollment of its first patient at one of its newest clinical sites, Columbia University, in its ongoing TIGeR-PaC Phase III clinical trial to evaluate the company’s therapy platform RenovoTAMP™ as a potential treatment option for locally advanced pancreatic cancer.